These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 24089060)

  • 1. (99m)Tc sestamibi as a prognostic factor of response to first-line therapy and outcome in patients with malignant lymphoma.
    Spyridonidis TJ; Matsouka P; Symeonidis A; Savvopoulos C; Vassilakos PJ; Apostolopoulos DJ
    Clin Nucl Med; 2013 Nov; 38(11):847-54. PubMed ID: 24089060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-phase Tc-99m MIBI scintigraphy as a therapeutic predictor in patients with non-Hodgkin's lymphoma.
    Song HC; Lee JJ; Bom HS; Chung IJ; Kim HJ; Park YK; Kim EE
    Clin Nucl Med; 2003 Jun; 28(6):457-62. PubMed ID: 12911092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of Tc-99m-MIBI performed during middle course of preoperative chemotherapy in patients with malignant bone and soft-tissue tumors.
    Wakabayashi H; Taki J; Inaki A; Sumiya H; Zen Y; Tsuchiya H; Kinuya S
    Clin Nucl Med; 2012 Jan; 37(1):1-8. PubMed ID: 22157020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tc-99m MIBI scintigraphy in multiple myeloma: prognostic value of different Tc-99m MIBI uptake patterns.
    Bacovsky J; Myslivecek M; Scudla V; Koranda P; Buriankova E; Minarik J; Pika T; Zapletalova J
    Clin Nucl Med; 2010 Sep; 35(9):667-70. PubMed ID: 20706038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of chemotherapy response using technetium-99M-sestamibi scintigraphy in untreated adult malignant lymphomas and comparison with other prognosis factors: a preliminary report.
    Kao CH; Tsai SC; Wang JJ; Ho YJ; Ho ST; Changlai SP
    Int J Cancer; 2001 Jul; 95(4):228-31. PubMed ID: 11400115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of chemotherapy response in untreated malignant lymphomas using technetium-99m methoxyisobutylisonitrile scan: comparison with P-glycoprotein expression and other prognostic factors. A preliminary peport.
    Liang JA; Shiau YC; Yang SN; Lin FJ; Kao A; Lee CC
    Jpn J Clin Oncol; 2002 Apr; 32(4):140-5. PubMed ID: 12072424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The clinical value of the 99Tcm-MIBI imaging in predicting the prognosis of malignant lymphoma].
    Qiao SK; Guo XN; Wang Y; Xu SR
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(28):2003-6. PubMed ID: 17923046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early prediction of histopathological tumor response to preoperative chemotherapy by Tc-99m MIBI imaging in bone and soft tissue sarcomas.
    Taki J; Inaki A; Wakabayashi H; Sumiya H; Tsuchiya H; Zen Y; Kinuya S
    Clin Nucl Med; 2010 Mar; 35(3):154-9. PubMed ID: 20173444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 99mTc-MIBI imaging as a predictor of therapy response in osteosarcoma compared with multidrug resistance-associated protein and P-glycoprotein expression.
    Burak Z; Moretti JL; Ersoy O; Sanli U; Kantar M; Tamgac F; Basdemir G
    J Nucl Med; 2003 Sep; 44(9):1394-401. PubMed ID: 12960182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quickly predicting chemotherapy response to paclitaxel-based therapy in non-small cell lung cancer by early technetium-99m methoxyisobutylisonitrile chest single-photon-emission computed tomography.
    Kao CH; Hsieh JF; Tsai SC; Ho YJ; Lee JK
    Clin Cancer Res; 2000 Mar; 6(3):820-4. PubMed ID: 10741702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technetium-99m-sestamethoxyisobutylisonitrile scan as a predictor of chemotherapy response in malignant lymphomas compared with P-glycoprotein expression, multidrug resistance-related protein expression and other prognosis factors.
    Kao CH; Tsai SC; Wang JJ; Ho YJ; Ho ST; Changlai SP
    Br J Haematol; 2001 May; 113(2):369-74. PubMed ID: 11380401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incremental diagnostic value of quantitative analysis of double phase Tc-99m MIBI scintimammography for the detection of primary breast cancer additive to visual analysis.
    Kim SJ; Kim IJ; Bae YT; Kim YK; Kim DS
    Breast Cancer Res Treat; 2004 Jan; 83(2):129-38. PubMed ID: 14997043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 99mTc-MIBI scintigraphy as a functional method for the evaluation of multidrug resistance in breast cancer patients.
    Sergieva SB; Timcheva KV; Hadjiolov ND
    J BUON; 2006; 11(1):61-8. PubMed ID: 17318954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of final tumor response to preoperative chemotherapy by Tc-99m MIBI imaging at the middle of chemotherapy in malignant bone and soft tissue tumors: comparison with Tl-201 imaging.
    Taki J; Higuchi T; Sumiya H; Tsuchiya H; Minato H; Tomita K; Tonami N
    J Orthop Res; 2008 Mar; 26(3):411-8. PubMed ID: 17960652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 99mTc-MIBI in the assessment of response to chemotherapy and detection of recurrences in bone and soft tissue tumours of the extremities.
    Moustafa H; Riad R; Omar W; Zaher A; Ebied E
    Q J Nucl Med; 2003 Mar; 47(1):51-7. PubMed ID: 12714955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of (99m)Tc-sestamibi washout in predicting response of locally advanced breast cancer to neoadjuvant chemotherapy.
    Sciuto R; Pasqualoni R; Bergomi S; Petrilli G; Vici P; Belli F; Botti C; Mottolese M; Maini CL
    J Nucl Med; 2002 Jun; 43(6):745-51. PubMed ID: 12050317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Residual tumor uptake of [99mTc]-sestamibi after neoadjuvant chemotherapy for locally advanced breast carcinoma predicts survival.
    Dunnwald LK; Gralow JR; Ellis GK; Livingston RB; Linden HM; Lawton TJ; Barlow WE; Schubert EK; Mankoff DA
    Cancer; 2005 Feb; 103(4):680-8. PubMed ID: 15637688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual-phase (99m)Tc-MIBI scintigraphy with delayed neck and thorax SPECT/CT and bone scintigraphy in patients with primary hyperparathyroidism: correlation with clinical or pathological variables.
    Qiu ZL; Wu B; Shen CT; Zhu RS; Luo QY
    Ann Nucl Med; 2014 Oct; 28(8):725-35. PubMed ID: 25120244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between 99mTc-MIBI uptake and angiogenesis in MIBI-positive breast lesions.
    Bekiş R; Degirmenci B; Aydin A; Ozdogan O; Canda T; Durak H
    Nucl Med Biol; 2005 Jul; 32(5):465-72. PubMed ID: 15982577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative technetium Tc 99m sestamibi SPECT imaging in the management of primary hyperparathyroidism in patients with concomitant multinodular goiter.
    Lorberboym M; Ezri T; Schachter PP
    Arch Surg; 2005 Jul; 140(7):656-60. PubMed ID: 16027330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.